|
RNF14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.538170E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.222310E-02 |
| Normal-vs-Stage2 |
6.513600E-01 |
| Normal-vs-Stage3 |
6.207200E-04 |
| Normal-vs-Stage4 |
1.869820E-02 |
| Stage1-vs-Stage2 |
1.360970E-01 |
| Stage1-vs-Stage3 |
7.352300E-02 |
| Stage1-vs-Stage4 |
3.365800E-01 |
| Stage2-vs-Stage3 |
2.135900E-02 |
| Stage2-vs-Stage4 |
5.285900E-02 |
| Stage3-vs-Stage4 |
6.629400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.937040E-03 |
| Normal-vs-AfricanAmerican |
5.557800E-03 |
| Normal-vs-Asian |
2.249800E-02 |
| Caucasian-vs-AfricanAmerican |
3.367400E-01 |
| Caucasian-vs-Asian |
2.874800E-01 |
| AfricanAmerican-vs-Asian |
8.090800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.278300E-03 |
| Normal-vs-Female |
2.902300E-03 |
| Male-vs-Female |
7.211800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.933500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.292230E-02 |
| Normal-vs-Age(61-80Yrs) |
2.800000E-03 |
| Normal-vs-Age(81-100Yrs) |
8.623000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.926000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.733000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.736800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.901000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.407600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.633420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.981410E-01 |
| Normal-vs-Grade 2 |
6.830000E-02 |
| Normal-vs-Grade 3 |
1.034300E-02 |
| Normal-vs-Grade 4 |
3.56599999999929E-05 |
| Grade 1-vs-Grade 2 |
5.954800E-01 |
| Grade 1-vs-Grade 3 |
7.165200E-01 |
| Grade 1-vs-Grade 4 |
5.160800E-01 |
| Grade 2-vs-Grade 3 |
5.388800E-01 |
| Grade 2-vs-Grade 4 |
8.959800E-03 |
| Grade 3-vs-Grade 4 |
4.137800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.798000E-01 |
| Normal-vs-ccB subtype |
1.382960E-03 |
| ccA subtype-vs-ccB subtype |
8.743500E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.010200E-02 |
| Normal-vs-N1 |
2.555400E-01 |
| N0-vs-N1 |
5.178600E-01 |
|
|
